Victrex plc (LON:VCT) insider Martin Court acquired 4 shares of the firm’s stock in a transaction that occurred on Thursday, August 16th. The stock was acquired at an average price of GBX 3,159 ($40.30) per share, with a total value of £126.36 ($161.19).
Martin Court also recently made the following trade(s):
- On Monday, July 16th, Martin Court acquired 4 shares of Victrex stock. The stock was acquired at an average price of GBX 2,992 ($38.17) per share, with a total value of £119.68 ($152.67).
- On Monday, June 18th, Martin Court acquired 4 shares of Victrex stock. The stock was acquired at an average price of GBX 3,046 ($38.86) per share, with a total value of £121.84 ($155.43).
Shares of Victrex stock traded down GBX 28 ($0.36) on Friday, reaching GBX 3,118 ($39.78). 42,707 shares of the company were exchanged, compared to its average volume of 274,177. Victrex plc has a one year low of GBX 1,826 ($23.29) and a one year high of GBX 2,772 ($35.36).
VCT has been the subject of a number of recent research reports. Peel Hunt reaffirmed a “hold” rating and set a GBX 2,400 ($30.62) price target on shares of Victrex in a research report on Tuesday, May 8th. Liberum Capital reaffirmed a “buy” rating on shares of Victrex in a research report on Monday, May 14th. JPMorgan Chase & Co. reaffirmed a “neutral” rating on shares of Victrex in a research report on Tuesday, May 15th. Credit Suisse Group upped their price target on Victrex from GBX 2,800 ($35.72) to GBX 2,850 ($36.36) and gave the stock an “outperform” rating in a research report on Tuesday, May 15th. Finally, HSBC started coverage on Victrex in a research report on Wednesday, May 23rd. They set a “hold” rating and a GBX 2,650 ($33.81) price target for the company. Two analysts have rated the stock with a sell rating, nine have assigned a hold rating and three have issued a buy rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus target price of GBX 2,463.58 ($31.43).
Victrex Company Profile
Victrex plc, through its subsidiaries, manufactures and sells polymers worldwide. It operates through two segments, Victrex Polymer Solutions and Invibio Biomaterial Solutions. The company offers VICTREX PEEK polymer materials; and biomaterial solutions for use in spine, dental, trauma, knee, cardiovascular, and orthopedic applications.
Recommended Story: Dividend Stocks – Are They Right For You?
Receive News & Ratings for Victrex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Victrex and related companies with MarketBeat.com's FREE daily email newsletter.